Ligand Pharmaceuticals Inc (LGND)
Cost of Revenue
$3.21M
Quarterly · Period ending: · USD
LGND Cost of Revenue
Latest reported$3.21Mperiod ending
Latest reported$3.21Mperiod ending
LGND Quarterly Cost of Revenue ($5.90M → $3.21M)
Quarterly cost of revenue
High-resolution chart · PNG
LGND cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 2,140,000 | |
| 1,903,000 | |
| 7,866,000 | |
| -1,888,000 | |
| -2,017,000 | |
| -2,343,000 | |
| 5,500,000 | |
| -900,000 | |
| -1,000,000 | |
| -500,000 | |
| -2,300,000 | |
| -1,800,000 | |
| -1,800,000 | |
| -1,800,000 | |
| -2,700,000 | |
| -2,500,000 | |
| -2,300,000 | |
| -2,300,000 | |
| -2,500,000 | |
| -4,600,000 | |
| -1,200,000 | |
| -1,100,000 | |
| -1,200,000 | |
| -900,000 | |
| 0 | |
| -700,000 | |
| 6,200,000 | |
| 6,400,000 | |
| 6,200,000 | |
| 5,900,000 |